Which insulin type is characterized as an intermediate acting insulin?

Humulin N is characterized as an intermediate-acting insulin, which plays a critical role in diabetes management by providing a more prolonged effect in lowering blood glucose levels. This type of insulin typically starts to work within 1 to 3 hours after injection, peaks between 4 to 12 hours, and can last up to 18 to 24 hours.

Intermediate-acting insulins, such as Humulin N, are often used to help control blood sugar levels between meals and overnight, making them indispensable in a patient’s basal-bolus insulin regimen. This contrasts with rapid-acting insulins like Novolog, Lispro, and Insulin glulisine, which are designed to act quickly after meals but do not provide sustained action.

Understanding the pharmacokinetics of Humulin N is essential for healthcare professionals to provide appropriate treatment plans for patients with diabetes, ensuring that they maintain stable glucose levels throughout the day.